Biogen (BIIB) total liabilities

Total liabilities · fiscal 2025
$11.18B

Biogen (BIIB) had total liabilities of $11.18B at the end of fiscal 2025 (December 31, 2025). That is 1.3% lower than the $11.33B of fiscal 2024. Figures as of 19 Nov 2026, 04:49 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Total liabilities, fiscal 2025
$11.18B
Change on fiscal 2024
−1.3%
Growth, 5 years
−4.3% a year
Growth, 10 years
+1.0% a year
Highest on record
$13.93Bfiscal 2020
Lowest on record
$2.29Bfiscal 2009
Fiscal years on record
182008–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Biogen total liabilities, in more detail

Over the five fiscal years to 2025 total liabilities shrank at a compound 4.3% a year; over ten years the rate was 1.0% a year. Across the 18 fiscal years on record (2008–2025), the highest was $13.93B in fiscal 2020 and the lowest $2.29B in fiscal 2009.

History · 18 fiscal years

Total liabilities by fiscal year

Biogen total liabilities, year by year

Biogen (BIIB) total liabilities by fiscal year
Fiscal yearTotal liabilitiesChangeYear ended
2025$11.18B 1.3% down
2024$11.33B 5.9% down
2023$12.05B 7.9% up
2022$11.17B 13.6% down
2021$12.92B 7.3% down
2020$13.93B 0.3% up
2019$13.90B 13.4% up
2018$12.26B 10.9% up
2017$11.05B 2.8% up
2016$10.75B 6.1% up
2015$10.13B 189.4% up
2014$3.50B 8.0% up
2013$3.24B 2.4% up
2012$3.17B 20.7% up
2011$2.62B 0.8% down
2010$2.64B 15.4% up
2009$2.29B 13.4% down
2008$2.65B—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total liabilities is everything the company owes at the fiscal year-end — borrowings, payables, deferred revenue, lease and pension obligations and the rest.

How to read it

It is broader than debt: read it against total assets, and remember that for a bank or an insurer customer deposits and policy reserves are liabilities too.

Total liabilities at health care companies of similar size

Total liabilities of Biogen and comparable companies
CompanyTotal liabilitiesFiscal year
Royalty Pharma RPRX$9.91B2025
Biogen BIIB$11.18B2025
GE HealthCare Technologies GEHC$26.31B2025
Alcon ALC$9.52B2025
Mettler-Toledo International MTD$3.74B2025
Centene CNC$56.69B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on BIIB

Biogen, figure by figure

Biogen (BIIB) overview: price, valuation and scorecardAll health care companies by market value

Biogen total liabilities: questions and answers

How large are Biogen's total liabilities?

Biogen (BIIB) had total liabilities of $11.18B at the end of fiscal 2025 (December 31, 2025). That is 1.3% lower than the $11.33B of fiscal 2024.

What is the growth rate of Biogen's total liabilities?

Over the five fiscal years to 2025 total liabilities shrank at a compound 4.3% a year; over ten years the rate was 1.0% a year.

What are the highest and lowest total liabilities figures on record for Biogen?

Across the 18 fiscal years on record (2008–2025), the highest was $13.93B in fiscal 2020 and the lowest $2.29B in fiscal 2009.

How is Biogen's total liabilities calculated?

Total liabilities is everything the company owes at the fiscal year-end — borrowings, payables, deferred revenue, lease and pension obligations and the rest. For Biogen it is on record here for 18 fiscal years, 2008 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Biogen (BIIB) total liabilities”, data as of 19 November 2026. https://funkfolio.com/stock/BIIB/total-liabilities

Underlying data: the company's filings with the SEC and Yahoo Finance.